Mach7 Technologies (M7T) Stock Price, News & Analysis

Company Overview

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe and internationally. The company offers enterprise diagnostic viewing, which includes eUnity zero-footprint viewer that connects departmental imaging from across the enterprise to deliver studies to care providers via the EMR. It also offers enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content. In addition, the company provides Enterprise PACS, an enterprise-ready imaging platform; and professional services, such as implementation, training, support, and maintenance services, as well as project management. Mach7 Technologies Limited was incorporated in 1977 and is headquartered in South Burlington, Vermont.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 272,627 shs
• Average Volume: N/A
• Market Capitalization: A$98.91 million
• P/E Ratio: N/A
• Dividend Yield: 3.37%
• Price Target: N/A
• Consensus Rating: N/A

M7T Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Mach7 Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Mach7 Technologies investors own include Farfetch (FTCH), Eton Pharmaceuticals (ETON), EQONEX (EQOS), Denison Mine (DNN), Denali Therapeutics (DNLI), Carbios SAS (COOSF) and Cleanspark (CLSK).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: ASX:M7T
• CIK: N/A
• Web: www.mach7t.com
• Phone: 802-861-7745
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: -23.2
• Net Income: -A$7.97 million
• Net Margins: -27.36%
• Pretax Margin: N/A
• Return on Equity: -15.00%
• Return on Assets: -8.38%

Debt

• Debt-to-Equity Ratio: 2.45
• Current Ratio: 2.25
• Quick Ratio: 3.05

Sales & Book Value

• Annual Sales: A$29.13 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.17
• Book Value: A$0.21 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 241,240,000
• Free Float: N/A
• Market Cap: A$98.91 million
• Optionable: Not Optionable
• Beta: 1.69